F090 Baseline characteristics do not affect the response to raloxifene hydrochloride in Japanese women with osteoporosis
H Morii, B. Mitlak(Eli Lilly (United States)), Jun Ishii(Dokkyo Medical University), William J. Huster(Eli Lilly (United States)), Yu Ohashi, Tatsuki Inoue, Tomotada Fujita, Hajime Orimo, Y. Taketani(The University of Tokyo)
Cited by 0
Related Papers
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
|New England Journal of Medicine|1997|1.6k
Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy
|Osteoporosis International|2004|320
Evaluation of vertebral fracture assessment by dual X-ray absorptiometry in a multicenter setting
|Osteoporosis International|2008|103
Identification of DBC1 as a transcriptional repressor for BRCA1
|British Journal of Cancer|2010|75
Multifunctional transcription factor TFII-I is an activator of BRCA1 function
|British Journal of Cancer|2011|29